Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer, and their families and friends, an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
The Cancer.Net Podcasts series has been awarded a Merit Award in the Digital Health Awards competition, which recognizes high-quality digital health resources for consumers and health professionals. The awards are organized by the Health Information Resource Center. Learn more about Cancer.Net awards and recognition.
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online (through the Internet) or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime. In addition, full written transcripts are available--click on the title of a podcast to read its transcript.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy-and-paste the link below into software that allows podcast subscriptions, such as iTunes or Juice.
In this podcast, we’ll discuss one study highlighted at ASCO’s 2015 Annual Meeting that examines whether taking an over-the-counter form of Vitamin B3 reduces the risk of being diagnosed with non-melanoma skin cancer.
Read a patient-friendly summary of this study.
In this podcast, we will discuss new recommendations for radiation therapy to treat locally advanced non-small cell lung cancer, developed by the American Society for Radiation Oncology and endorsed by ASCO.
Today’s podcast is about new advances in immunotherapy for treating lung cancer, including the recent FDA approval of nivolumab to treat advanced squamous non-small cell lung cancer (NSCLC).
This podcast is part of a series for patients who have just been diagnosed with a specific genitourinary, or GU cancer. In this series, Dr. Charles Ryan, a medical oncologist and associate professor who specializes in the genitourinary tract at the UCSF Helen Diller Family Comprehensive Cancer Center, speaks with experts on specific GU cancers to shed light on what happens after an initial diagnosis.
Today’s guest is Dr. Brian Rini, an associate professor of medicine and a staff member in the Department of Solid Tumor Oncology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Ryan and Dr. Rini discuss the decisions that doctors make when a patient is diagnosed with kidney cancer, including some of the factors that go into recommending certain treatment options.
In this podcast, we’ll discuss the role of pathologists in cancer care.
Today’s podcast is about living with lymphedema, a build-up of fluid that may occur after cancer treatment. This podcast will be led by Dr. Judith Nudelman, a family physician and certified lymphedema therapist.
A diagnosis of cancer can bring up many emotions and cause stress, anxiety, or depression for both patients and their families. In this podcast, we’ll discuss how seeing a Licensed Marriage and Family Therapist can help a person with cancer, how to find a marriage and family therapist, and what to expect from your visits.
In this podcast, we’ll discuss a study highlighted at the 2015 Gastrointestinal Cancers Symposium that examines the relationship between Vitamin D levels and survival in patients with advanced colorectal cancer.
In this podcast, we’ll discuss some of the breast cancer research announced at the 2014 San Antonio Breast Cancer Symposium, held December ninth through the thirteenth in San Antonio, Texas.
In this podcast, we’ll discuss some of the research on multiple myeloma announced at the 2014 Annual Meeting of the American Society of Hematology, held December fifth through the ninth in San Francisco, California.